About Hugo Beekman
Form D filings for EvolveImmune Therapeutics Holding Company in 2020 list Hugo Beekman as director.
Hugo Beekman first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Hugo Beekman in the role, so the role may have started earlier or lasted longer.
EvolveImmune Therapeutics Holding Company, LLC
Director
2020 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.
Key Colleagues at Startups
The people Hugo Beekman works with at each company, as listed on that company's latest Form D.
EvolveImmune Therapeutics Holding Company, LLC · Form D, Jan 17, 2020
SB
Stephen Bloch
Co-founder and Chief Executive Officer
AB
Alessandra Di Bacco
Director
DP
Denis Patrick
Director